These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 15737523

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Rise of Streptococcus pneumoniae isolates containing both erm(B) and mef(E) genes from an adult tertiary care community hospital system.
    DiPersio LP, DiPersio JR, Beach JA, DeFine LA.
    Diagn Microbiol Infect Dis; 2006 Aug; 55(4):327-31. PubMed ID: 16626911
    [Abstract] [Full Text] [Related]

  • 3. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002.
    Farrell DJ, Jenkins SG.
    J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i17-22. PubMed ID: 15265832
    [Abstract] [Full Text] [Related]

  • 4. Distribution and antibacterial susceptibility of macrolide resistance genotypes in Streptococcus pneumoniae: PROTEKT Year 5 (2003-2004).
    Farrell DJ, Couturier C, Hryniewicz W.
    Int J Antimicrob Agents; 2008 Mar; 31(3):245-9. PubMed ID: 18178388
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).
    Tazumi A, Maeda Y, Goldsmith CE, Coulter WA, Mason C, Millar BC, McCalmont M, Rendall J, Elborn JS, Matsuda M, Moore JE.
    J Antimicrob Chemother; 2009 Sep; 64(3):501-6. PubMed ID: 19584106
    [Abstract] [Full Text] [Related]

  • 9. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
    Wierzbowski AK, Nichol K, Laing N, Hisanaga T, Nikulin A, Karlowsky JA, Hoban DJ, Zhanel GG.
    J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
    [Abstract] [Full Text] [Related]

  • 10. Molecular characterisation of Hungarian macrolide-resistant Streptococcus pneumoniae isolates, including three highly resistant strains with the mef gene.
    Dobay O, Rozgonyi F, Amyes SG.
    Int J Antimicrob Agents; 2005 Jun; 25(6):488-95. PubMed ID: 15878263
    [Abstract] [Full Text] [Related]

  • 11. Distribution of capsular serotypes and macrolide resistance mechanisms among macrolide-resistant Streptococcus pneumoniae isolates in Korea.
    Bae S, Lee K.
    Diagn Microbiol Infect Dis; 2009 Feb; 63(2):213-6. PubMed ID: 19097840
    [Abstract] [Full Text] [Related]

  • 12. [Characterization of macrolide-resistance mediated by transposable elements Tn1545 and Tn917 in clinical Isolates of Streptococcus pneumoniae].
    Wu WJ, Hong XH, Zhang H, Jiang YQ, Lu Q, Ni YX.
    Zhonghua Yi Xue Za Zhi; 2006 Mar 07; 86(9):605-8. PubMed ID: 16681905
    [Abstract] [Full Text] [Related]

  • 13. Prevalence and antibacterial susceptibility of mef(A)-positive macrolide-resistant Streptococcus pneumoniae over 4 years (2000 to 2004) of the PROTEKT US Study.
    Farrell DJ, File TM, Jenkins SG.
    J Clin Microbiol; 2007 Feb 07; 45(2):290-3. PubMed ID: 17093012
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of mef and ermB genes in invasive pediatric erythromycin-resistant Streptococcus pneumoniae isolates from Argentina.
    Corso A, Faccone D, Gagetti P, Pace J, Regueira M, Pace J, Argentinean Sireva Working Group.
    Rev Argent Microbiol; 2009 Feb 07; 41(1):29-33. PubMed ID: 19391523
    [Abstract] [Full Text] [Related]

  • 15. Macrolide-resistance mechanisms in Streptococcus pneumoniae isolates from Belgium.
    Van Eldere J, Meekers E, Lagrou K, Massonet C, Canu A, Devenyns I, Verhaegen J, Syrogiannopoulos G, Leclercq R.
    Clin Microbiol Infect; 2005 Apr 07; 11(4):332-4. PubMed ID: 15760433
    [Abstract] [Full Text] [Related]

  • 16. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A, Koncan R, Vitali LA, Cornaglia G.
    J Antimicrob Chemother; 2007 Jun 07; 59(6):1171-6. PubMed ID: 17405779
    [Abstract] [Full Text] [Related]

  • 17. mef(A) is the predominant macrolide resistance determinant in Streptococcus pneumoniae and Streptococcus pyogenes in Germany.
    Bley C, van der Linden M, Reinert RR.
    Int J Antimicrob Agents; 2011 May 07; 37(5):425-31. PubMed ID: 21419605
    [Abstract] [Full Text] [Related]

  • 18. Molecular characterisation of Canadian paediatric multidrug-resistant Streptococcus pneumoniae from 1998-2004.
    Zhanel GG, Wang X, Nichol K, Nikulin A, Wierzbowski AK, Mulvey M, Hoban DJ.
    Int J Antimicrob Agents; 2006 Nov 07; 28(5):465-71. PubMed ID: 17049211
    [Abstract] [Full Text] [Related]

  • 19. [Differentiation of resistance phenotypes among erythromycin-resistant streptococci].
    Bejuk D.
    Acta Med Croatica; 2004 Nov 07; 58(4):301-6. PubMed ID: 15700686
    [Abstract] [Full Text] [Related]

  • 20. Genotypes of macrolide-resistant pneumococci from children in southwestern Japan: raised incidence of strains that have both erm(B) and mef(A) with serotype 6B clones.
    Ikenaga M, Kosowska-Shick K, Gotoh K, Hidaka H, Koga H, Masunaga K, Nagai K, Tsumura N, Appelbaum PC, Matsuishi T.
    Diagn Microbiol Infect Dis; 2008 Sep 07; 62(1):16-22. PubMed ID: 18068325
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.